OS THERAPIES INCORPORATED

NYSE:OSTX
Annual Meeting

of Shareholders

MEETING DATE

09/09/2026
DEF 14A FILED
07/24/2026
PUBLISHED
07/24/2026 8:16 pm
TIME TO PUBLISH
07/26/2026
METHODOLOGY
approve
EXCHANGE NYSE:OSTX · CUSIP 68764Y207 · CLASS common stock and Series A senior convertible preferred stock · CIK 0001795091

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
0
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
The Election of Directors Proposal
board
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The filing states stockholders will elect six directors to serve until the 2027 annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
The Amended and Restated Plan Proposal
compensation
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The filing states 1,575,463 shares remained available under the Existing Plan as of July 21, 2026.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
The Auditor Ratification Proposal
auditor
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The Audit Committee concluded MaloneBailey's services would not affect its independence.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

0b8d9c845d04b97000ed2d6d8c09ba6b5b102dd060a8ac5d6a257ef8affe33f1

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates